Novo Nordisk Sues Hims & Hers Over Wegovy Copycats; HIMS Stock Falls
Novo vs. Hims: Weight-Loss Drug Battle Sends Shockwaves Through Health Market (Overview) Novo Nordisk files lawsuit against Hims & Hers over Wegovy copycats Court ban requested on compounded versions of semaglutide drugs FDA signals crackdown on mass-marketed GLP-1 compounds Hims pulls its new obesity pill after regulatory pressure Hims stock plunges up to 27% in […]
Novo Nordisk Sues Hims & Hers Over Wegovy Copycats; HIMS Stock Falls Read More »







